This morning, Novartis CEO Joe Jimenez announced fourth quarter and full year 2017 results. In his remarks Jimenez said: “It was a landmark year for innovation resulting in a rich late-stage pipeline. With several key launches on the horizon and our new operating model in place, Novartis is poised for sustainable growth.”
Vas Narasimhan, designated CEO from February 1, commented: “I want to thank Joe and the Board for their leadership and guidance as I transition to my new role. I feel privileged to lead Novartis at this exciting time.”
Download the media release
English (PDF 0.4 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.5 MB)
2017 At A Glance

Watch the Webcast
Download the presentation
Media Presentation (PDF 10 MB)
Annual Report 2017
The Novartis Annual Report 2017 reviews the company’s strategy and annual performance.
Visit the Annual Report
Novartis Pipeline
For a detailed review of selected projects in confirmatory development, download the complete Novartis Pipeline (PDF 92 KB) as of December 31, 2017.
Learn more about our Clinical Pipeline
Novartis Corporate Fact Sheet
The corporate fact sheet provides a comprehensive overview of Novartis overall as well as our divisions (Pharmaceuticals, Alcon, Sandoz), our research (NIBR) and development (Global Drug Development) organizations, and outlines our commitment to associates as well as Corporate Citizenship.